![Robert Holmlin](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Robert Holmlin
Direktor/Vorstandsmitglied bei
Xagenic, Inc.
Vermögen: 1 208 $ am 31.08.2026
Profil
Robert Erik Holmlin was the founder of GeneOhm Sciences, Inc., founded in 2001, where the title held was Vice President-Business Development from 2001 to 2012.
Current jobs include Director at Xagenic, Inc. since 2012 and Director at Innovatus Life Sciences Acquisition Corp.
since 2021.
Former jobs include President, CEO, CFO & Director at Bionano Genomics, Inc. from 2024 to 2026; President & Chief Executive Officer at GenVault Corp.
from 2010 to 2011; Independent Director at Nanosphere, Inc.; Director at Applied Proteomics, Inc.; Entrepreneur-in-Residence at Domain Associates LLC; Vice President-Marketing & Development at Becton, Dickinson & Co. from 2006 to 2008; and Chief Commercial Officer at Exiqon A from 2008 to 2009.
Education includes an MBA from The Trustees of Columbia University in The City of New York, a doctorate from California Institute of Technology, an undergraduate degree from Occidental College, and an MBA from the University of California, Berkeley.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 19.03.2026 | 990 ( 0.01% ) | 1 208 $ | 31.08.2026 |
Aktive Positionen von Robert Holmlin
| Unternehmen | Position | Beginn |
|---|---|---|
Xagenic, Inc.
 Xagenic, Inc. Medical SpecialtiesHealth Technology Develops automated molecular diagnostic platform will enable widespread decentralized testing to be performed outside of clinical laboratories | Direktor/Vorstandsmitglied | 11.09.2012 |
Innovatus Life Sciences Acquisition Corp.
 Innovatus Life Sciences Acquisition Corp. Financial ConglomeratesFinance Operates as a blank check company | Direktor/Vorstandsmitglied | 01.03.2021 |
Ehemalige bekannte Positionen von Robert Holmlin
| Unternehmen | Position | Ende |
|---|---|---|
| BIONANO GENOMICS, INC. | Vorstandsvorsitzender | 05.05.2026 |
GenVault Corp.
 GenVault Corp. Packaged SoftwareTechnology Services Provides integration of biosample transport, storage, and retrieval services | Vorstandsvorsitzender | 01.02.2011 |
| EXIQON A/S | Corporate Officer/Principal | 01.11.2009 |
| BECTON, DICKINSON AND COMPANY | Vertrieb & Marketing | 01.07.2008 |
Domain Associates LLC
 Domain Associates LLC Investment ManagersFinance Domain Associates invests in both private and public companies located in the United States. The firm focuses on pharmaceuticals, diagnostics and medical device sectors. It provides financing for seed, early and late stage capital requirements. It takes a seat on the board of directors. | Corporate Officer/Principal | - |
Ausbildung von Robert Holmlin
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
69
Beziehungen ersten Grades
14
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 14 |
|---|---|
Becton, Dickinson & Co.
 Becton, Dickinson & Co. Medical SpecialtiesHealth Technology Manufactures and sells medical supplies, devices, laboratory equipment & diagnostic products | Health Technology |
GeneOhm Sciences, Inc.
 GeneOhm Sciences, Inc. Medical SpecialtiesHealth Technology Develops molecular diagnostic products | Health Technology |
Nanosphere, Inc.
 Nanosphere, Inc. Medical SpecialtiesHealth Technology Develops molecular testing systems | Health Technology |
GenVault Corp.
GenVault Corp. Packaged SoftwareTechnology Services Provides integration of biosample transport, storage, and retrieval services | Technology Services |
Domain Associates LLC
Domain Associates LLC Investment ManagersFinance Domain Associates invests in both private and public companies located in the United States. The firm focuses on pharmaceuticals, diagnostics and medical device sectors. It provides financing for seed, early and late stage capital requirements. It takes a seat on the board of directors. | Finance |
The Trustees of Columbia University in The City of New York
 The Trustees of Columbia University in The City of New York Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
California Institute of Technology
 California Institute of Technology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Occidental College
 Occidental College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of California, Berkeley
 University of California, Berkeley Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Exiqon A/S
 Exiqon A/S Miscellaneous Commercial ServicesCommercial Services Engages in the pharmaceutical industry | Commercial Services |
Bionano Genomics, Inc.
 Bionano Genomics, Inc. BiotechnologyHealth Technology Develops technologies for analysis of large biological molecules | Health Technology |
Applied Proteomics, Inc.
 Applied Proteomics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company focused on developing protein-based and blood-based diagnostic tests for cancer detection | Health Technology |
Xagenic, Inc.
Xagenic, Inc. Medical SpecialtiesHealth Technology Develops automated molecular diagnostic platform will enable widespread decentralized testing to be performed outside of clinical laboratories | Health Technology |
Innovatus Life Sciences Acquisition Corp.
Innovatus Life Sciences Acquisition Corp. Financial ConglomeratesFinance Operates as a blank check company | Finance |
